Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176458 · ClinicalTrials.gov registry record · NA
Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04176458 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants.
The verdict
NCT04176458, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The aim of this project is assess a non-invasive functional liver tests in patients with the Fontan circulation that may be used for prognostic purposes. Specifically, we aim to determine whether there are alterations in Methacetin Breath Test (MBT) in the Fontan patient and if so, whether it is related to conventional tests of liver and cardiac function. The hypothesis is that MBT CPDR 20 in the Fontan patient is abnormal as a result of alterations in liver perfusion, liver cell metabolic capability and transhepatic resistance secondary to hemodynamics unique to the Fontan as well as end-organ liver damage. Due to lack of robust biomarkers or other risk stratification schemes, we aim to determine whether there is prognostic value in hepatic MBT CPDR 20 in the Fontan patient. Aims - The aims of this study are three-fold: 1. To measure MBT parameter in a cohort of patients with Congestive (Dilated) Cardiomyopathy and a group of Fontan patients and compare results to published normal controls. 2. To explore any association between MBT parameter and clinical parameters already available, including Fontan hemodynamics as assessed by either of the following tests: cardiac catheterization, echocardiography, non-invasive imaging of the liver (CT or MRI), non-invasive assessment of liver stiffness (ARFI, MRE or Fibroscan), laboratory investigations, and clinical characteristics (i.e. age of patient, time since Fontan operation, type of Fontan etc.) within 12 months of the study. 3. To determine whether MBT is predictive of clinical outcomes: heart failure, clinically significant ascites, and time to transplant or death.
Interventions
- DEVICE Methacetin Breath Test (MBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-04-21 |
| Est. Completion | 2021-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176458
The ClinicalTrials.gov registry entry for NCT04176458 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methacetin Breath Test (MBT) is the first listed.
NCT04176458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04176458 about?
NCT04176458 is a clinical study titled "Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease". The aim of this project is assess a non-invasive functional liver tests in patients with the Fontan circulation that may be used for prognostic purposes. Specifically, we aim to determine whether there are alterations in Methacetin Breath Test (MBT) in the Fontan patient and if so, whether it is rel...
What is the current status of trial NCT04176458?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-04-21. Estimated completion is 2021-03-19.
What interventions are being tested in trial NCT04176458?
The interventions under investigation include: Methacetin Breath Test (MBT) (DEVICE).
Who is sponsoring clinical trial NCT04176458?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.